The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter

By sjmartinez • August 24, 2023

Butler J, Khan MS, Fonarow GC. The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter. J Am Coll Cardiol. 2023 Sep 5;82(10):1027-1029. doi: 10.1016/j.jacc.2023.06.007. Epub 2023 Aug 21. PMID: 37610399.

Tags: Cardiology/Epi, Clinical Trial, geographic region, heart failure, Publications, sodium-glucose co-transporter-2 inhibitors

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart

Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL. Bioelectronic block of stellate ganglia[...]

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable

Tobis JM, Carroll JD. Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable? Circulation. 2024 Nov 19;150(21):1669-1670. doi: 10.1161/CIRCULATIONAHA.124.071851. Epub 2024 Nov 18.[...]

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With[...]